Deglutition Disorders

Pipeline Programs

Companies

Clinical Trials

1 recruiting

Approved Products

Pipeline by Development Stage

Preclinical

Phase 1

Phase 1/2

Phase 2

Phase 2/3

Phase 3

On Market

Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

3 companies ranked by most advanced pipeline stage

Pre

P1/2

P2/3

Mkt

Purdue PharmaCT - Stamford

1 program

Tele-EaT SensorsPhase 11 trial

Active Trials

NCT04243577Completed70Est. Jul 2023

Human BioSciencesWV - Martinsburg

1 program

AspirometerN/A1 trial

Active Trials

NCT06637774Completed50Est. May 2023

NeurophetKorea - Seoul

1 program

Optimized transcranial Direct Current StimulationN/A1 trial

Active Trials

NCT06305949Recruiting30Est. Jun 2026

Trial Timeline

Clinical trial activity over time

2021

2022

2023

2024

2025

2026

Purdue PharmaTele-EaT Sensors

NeurophetOptimized transcranial Direct Current Stimulation

Human BioSciencesAspirometer

Clinical Trials (3)

Total enrollment: 150 patients across 3 trials

NCT04243577 Purdue PharmaTele-EaT Sensors

Wearable Monitoring Systems for Swallowing Function and Disorders

Start: Sep 2018Est. completion: Jul 202370 patients

Phase 1Completed

NCT06305949 NeurophetOptimized transcranial Direct Current Stimulation

Clinical Trial on the Safety and Efficacy of Optimized Transcranial Direct Current Stimulation for the Swallowing Function in Patients With Post-Stroke Dysphagia

Start: Apr 2024Est. completion: Jun 202630 patients

N/ARecruiting

NCT06637774 Human BioSciencesAspirometer

The Aspirometer: A Noninvasive Tool for Detecting Aspiration Aim 3

Start: Sep 2022Est. completion: May 202350 patients

N/ACompleted

Phase Legend

Preclinical— Lab & animal studies

Phase 1— Safety & dosing

Phase 2— Efficacy testing

Phase 3— Large-scale trials

On Market— Approved & available

Key Insights

1 actively recruiting trials targeting 150 patients

4 companies competing in this space

The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.